In episode 26 the pharmaphorum podcast hears from David Solomon, a 30-year life sciences industry veteran who recently took up the position of CEO at the Paris-based biopharmaceutical company Pharnext.
Amgen and science education: the pharmaphorum podcast
UK pharma leadership and COVID-19: the pharmaphorum podcast
Eisai and Alexa skills in epilepsy: the pharmaphorum podcast
Digital health and interoperability: the pharmaphorum podcast
Roche, big data and patient outcomes: the pharmaphorum podcast
Pfizer and the UK cancer landscape: the pharmaphorum podcast
Life sciences leadership: the pharmaphorum podcast
AstraZeneca and lung cancer: the pharmaphorum podcast
Lung cancer’s patient information gap: the pharmaphorum podcast
The state of UK drug discovery: the pharmaphorum podcast
Addressing global health challenges: the pharmaphorum podcast
Gene therapy and market access: the pharmaphorum podcast
AMR research and Matoke Pharma: the pharmaphorum podcast
GSK and digital disruption: the pharmaphorum podcast
Ipsen on neurotoxin research: the pharmaphorum podcast
Successful medical marketing teams: the pharmaphorum podcast
Biotech strategy and nanomedicine: the pharmaphorum podcast
Commercialising orphan drugs: the pharmaphorum podcast
The future biosimilar landscape: the pharmaphorum podcast
Nimble consumer healthcare innovation: the pharmaphorum podcast
Create your
podcast in
minutes
It is Free
DNA Today: A Genetics Podcast
Short Wave
Stuff To Blow Your Mind
Unexplainable
Speaking of Psychology